STOCK TITAN

[8-K] Amerant Bancorp Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

ALT5 Sigma Corporation (NASDAQ: ALTS) filed an 8-K announcing the May 9 2025 acquisition of “Mswipe,” a Canada-based provider of multi-currency, fiat- and crypto-enabled payment card solutions available on Visa and Mastercard networks.

  • Strategic rationale: Mswipe’s B2B platform extends ALT5’s existing digital-asset settlement offering by adding globally usable physical & virtual cards, real-time FX/crypto conversion and robust compliance.
  • Consideration: (i) 1 million restricted ALTS shares valued at $6.10 each (~$6.1 M); (ii) 500 k four-year warrants exercisable at $5.50; (iii) $4.8 M in shares of spin-off Alyea Therapeutics; (iv) two 14-month promissory notes totalling ~$1 M at 3.99% interest; and (v) assumption/reset of an existing $5.1 M target-level note.
  • Contingent payout: Sellers may receive a one-time earn-out of up to $20 M (cash or stock) if the operating subsidiaries reach ≥$15 M annualised or actual revenue.
  • Audited FY25/FY24 Mswipe financials (Ex. 99.1) and unaudited pro-forma combined statements (Ex. 99.2) were filed; a press release (Ex. 99.3) was issued on May 13 2025.

No immediate revenue or EPS guidance was provided. The transaction is expected to close seamlessly as ALT5 integrates card issuance, aiming to bridge digital assets with traditional payment rails.

ALT5 Sigma Corporation (NASDAQ: ALTS) ha depositato un modulo 8-K annunciando l'acquisizione, avvenuta il 9 maggio 2025, di “Mswipe”, un fornitore canadese di soluzioni di pagamento con carta multi-valuta, abilitato sia per valute fiat che criptovalute, disponibile sulle reti Visa e Mastercard.

  • Razionale strategico: La piattaforma B2B di Mswipe amplia l'offerta di ALT5 nell’ambito della liquidazione di asset digitali, integrando carte fisiche e virtuali utilizzabili a livello globale, conversione FX/crypto in tempo reale e un solido sistema di conformità normativa.
  • Controvalore: (i) 1 milione di azioni ALTS vincolate valutate a 6,10 $ ciascuna (~6,1 milioni di $); (ii) 500.000 warrant con durata di quattro anni esercitabili a 5,50 $; (iii) 4,8 milioni di $ in azioni della società spin-off Alyea Therapeutics; (iv) due cambiali della durata di 14 mesi per un totale di circa 1 milione di $ con un interesse del 3,99%; e (v) assunzione/azzeramento di una cambiale esistente da 5,1 milioni di $ a livello target.
  • Pagamento condizionato: I venditori potrebbero ricevere un earn-out una tantum fino a 20 milioni di $ (in contanti o azioni) se le controllate operative raggiungono un fatturato annualizzato o effettivo pari o superiore a 15 milioni di $.
  • Sono stati depositati i bilanci Mswipe auditati per gli esercizi FY25/FY24 (Ex. 99.1) e i rendiconti combinati pro-forma non auditati (Ex. 99.2); inoltre, il 13 maggio 2025 è stato diffuso un comunicato stampa (Ex. 99.3).

Non sono state fornite indicazioni immediate su ricavi o utili per azione. La transazione dovrebbe concludersi senza intoppi mentre ALT5 integra l’emissione delle carte, puntando a collegare gli asset digitali con i tradizionali sistemi di pagamento.

ALT5 Sigma Corporation (NASDAQ: ALTS) presentó un formulario 8-K anunciando la adquisición el 9 de mayo de 2025 de “Mswipe”, un proveedor canadiense de soluciones de tarjetas de pago multi-moneda, compatibles con moneda fiduciaria y criptomonedas, disponibles en las redes Visa y Mastercard.

  • Justificación estratégica: La plataforma B2B de Mswipe amplía la oferta existente de ALT5 en liquidación de activos digitales, añadiendo tarjetas físicas y virtuales de uso global, conversión en tiempo real de FX/crypto y un cumplimiento normativo sólido.
  • Consideración: (i) 1 millón de acciones restringidas de ALTS valoradas en $6.10 cada una (~$6.1 millones); (ii) 500,000 warrants a cuatro años ejercitables a $5.50; (iii) $4.8 millones en acciones de la escisión Alyea Therapeutics; (iv) dos pagarés a 14 meses por un total de aproximadamente $1 millón con interés del 3.99%; y (v) asunción/reinicio de un pagaré existente por $5.1 millones a nivel objetivo.
  • Pago contingente: Los vendedores podrían recibir un pago adicional único de hasta $20 millones (en efectivo o acciones) si las subsidiarias operativas alcanzan ingresos anuales o efectivos iguales o superiores a $15 millones.
  • Se presentaron los estados financieros auditados de Mswipe para FY25/FY24 (Ex. 99.1) y los estados combinados pro forma no auditados (Ex. 99.2); además, se emitió un comunicado de prensa el 13 de mayo de 2025 (Ex. 99.3).

No se proporcionaron previsiones inmediatas de ingresos o ganancias por acción. Se espera que la transacción se cierre sin problemas mientras ALT5 integra la emisión de tarjetas, con el objetivo de conectar los activos digitales con los sistemas tradicionales de pago.

ALT5 Sigma Corporation (NASDAQ: ALTS)는 2025년 5월 9일 캐나다 기반의 다중 통화, 법정화폐 및 암호화폐 지원 결제 카드 솔루션 제공업체인 “Mswipe” 인수를 발표하는 8-K를 제출했습니다. Mswipe의 솔루션은 Visa 및 Mastercard 네트워크에서 이용 가능합니다.

  • 전략적 배경: Mswipe의 B2B 플랫폼은 ALT5의 기존 디지털 자산 결제 서비스를 확장하여 전 세계에서 사용할 수 있는 실물 및 가상 카드, 실시간 FX/암호화폐 환전 및 강력한 컴플라이언스를 추가합니다.
  • 대가: (i) 주당 6.10달러로 평가된 100만 주의 제한된 ALTS 주식 (~610만 달러); (ii) 행사가 5.50달러인 4년 만기 워런트 50만 주; (iii) 스핀오프 회사 Alyea Therapeutics 주식 480만 달러 상당; (iv) 3.99% 이자의 14개월 만기 약속어음 2건, 총 약 100만 달러; (v) 기존 510만 달러 규모의 타깃 레벨 노트 인수 및 재설정.
  • 조건부 지급: 운영 자회사가 연간 또는 실제 매출 1,500만 달러 이상을 달성할 경우 판매자는 최대 2,000만 달러(현금 또는 주식)의 일회성 추가 보상을 받을 수 있습니다.
  • 감사된 FY25/FY24 Mswipe 재무제표(Ex. 99.1) 및 감사되지 않은 프로포르마 결합 재무제표(Ex. 99.2)가 제출되었으며, 2025년 5월 13일 보도자료(Ex. 99.3)가 발표되었습니다.

즉각적인 매출 또는 주당순이익 전망은 제공되지 않았습니다. 거래는 ALT5가 카드 발행을 통합하면서 원활하게 마무리될 것으로 예상되며, 디지털 자산과 전통적인 결제 시스템을 연결하는 것을 목표로 합니다.

ALT5 Sigma Corporation (NASDAQ : ALTS) a déposé un formulaire 8-K annonçant l'acquisition, effective au 9 mai 2025, de « Mswipe », un fournisseur canadien de solutions de cartes de paiement multi-devises, compatibles avec les monnaies fiduciaires et cryptomonnaies, disponibles sur les réseaux Visa et Mastercard.

  • Justification stratégique : La plateforme B2B de Mswipe étend l'offre existante d'ALT5 en matière de règlement d'actifs numériques en ajoutant des cartes physiques et virtuelles utilisables mondialement, une conversion FX/crypto en temps réel et une conformité rigoureuse.
  • Contrepartie : (i) 1 million d'actions ALTS restreintes valorisées à 6,10 $ chacune (~6,1 M$) ; (ii) 500 000 bons de souscription de quatre ans exerçables à 5,50 $ ; (iii) 4,8 M$ en actions de la société dérivée Alyea Therapeutics ; (iv) deux billets à ordre de 14 mois totalisant environ 1 M$ à un taux d'intérêt de 3,99 % ; et (v) prise en charge/remise à zéro d'un billet à ordre existant de 5,1 M$.
  • Paiement conditionnel : Les vendeurs peuvent recevoir un earn-out unique allant jusqu'à 20 M$ (en numéraire ou en actions) si les filiales opérationnelles atteignent un chiffre d'affaires annuel ou réel supérieur ou égal à 15 M$.
  • Les états financiers audités de Mswipe pour les exercices FY25/FY24 (Ex. 99.1) ainsi que les états pro forma combinés non audités (Ex. 99.2) ont été déposés ; un communiqué de presse (Ex. 99.3) a été publié le 13 mai 2025.

Aucune prévision immédiate de chiffre d'affaires ou de bénéfice par action n'a été fournie. La transaction devrait se clôturer sans encombre tandis qu'ALT5 intègre l'émission de cartes, visant à relier les actifs numériques aux systèmes de paiement traditionnels.

ALT5 Sigma Corporation (NASDAQ: ALTS) reichte ein 8-K ein und gab die Übernahme von „Mswipe“ zum 9. Mai 2025 bekannt, einem kanadischen Anbieter von Multiwährungs-Zahlungskartenlösungen, die sowohl Fiat- als auch Krypto-Zahlungen über Visa- und Mastercard-Netzwerke ermöglichen.

  • Strategischer Hintergrund: Die B2B-Plattform von Mswipe erweitert das bestehende Angebot von ALT5 im Bereich der Abwicklung digitaler Vermögenswerte durch global einsetzbare physische und virtuelle Karten, Echtzeit-FX-/Krypto-Umrechnung und umfassende Compliance.
  • Gegenleistung: (i) 1 Million eingeschränkte ALTS-Aktien im Wert von je 6,10 $ (~6,1 Mio. $); (ii) 500.000 vierjährige Warrants mit Ausübungspreis von 5,50 $; (iii) 4,8 Mio. $ in Aktien des Spin-offs Alyea Therapeutics; (iv) zwei 14-monatige Schuldscheine über insgesamt ca. 1 Mio. $ mit 3,99 % Zinsen; und (v) Übernahme/Neufestsetzung eines bestehenden Schuldscheins in Höhe von 5,1 Mio. $.
  • Bedingte Auszahlung: Die Verkäufer können eine einmalige Earn-out-Zahlung von bis zu 20 Mio. $ (in bar oder Aktien) erhalten, falls die operativen Tochtergesellschaften einen annualisierten oder tatsächlichen Umsatz von ≥ 15 Mio. $ erreichen.
  • Die geprüften Finanzberichte von Mswipe für FY25/FY24 (Ex. 99.1) sowie die ungeprüften pro-forma-Konzernabschlüsse (Ex. 99.2) wurden eingereicht; eine Pressemitteilung (Ex. 99.3) wurde am 13. Mai 2025 veröffentlicht.

Es wurden keine unmittelbaren Umsatz- oder Ergebnisprognosen gegeben. Die Transaktion soll nahtlos abgeschlossen werden, während ALT5 die Kartenausgabe integriert und darauf abzielt, digitale Vermögenswerte mit traditionellen Zahlungssystemen zu verbinden.

Positive
  • Strategic fit: Adds globally accepted crypto-to-fiat cards, expanding ALT5’s addressable market.
  • Low cash outlay: Majority of consideration in stock and warrants preserves cash.
  • Earn-out structure: Aligns seller incentives with future revenue performance.
Negative
  • Share dilution: 1 M new shares plus 0.5 M warrants (~6% potential increase in float).
  • Contingent liability: Up to $20 M earn-out could strain capital if triggered.
  • Additional debt: Assumed and issued notes add ≈$6.1 M principal at 3.99%.

Insights

TL;DR Acquisition broadens ALTS’s payment stack but adds dilution and contingent liabilities; net impact depends on Mswipe’s revenue realisation.

The structure mixes equity (≈$6.1 M shares + 0.5 M warrants) and modest debt, limiting upfront cash burn. However, potential $20 M earn-out could become material if revenue milestones are met, pressuring future liquidity. Assuming ALTS’s ~25 M share float, new shares/warrants imply ~6% potential dilution. Strategically, card issuance enhances stickiness and cross-sell, positioning ALTS against larger crypto-to-fiat processors like Wirex and Coinbase Card. Lack of historical Mswipe revenue/profit data clouds accretion analysis; investors should scrutinise Ex. 99.1/99.2 for margin impact. Overall, the deal is impactful but valuation risk remains.

TL;DR Adding Visa/Mastercard cards gives ALT5 instant global acceptance and regulatory cover, a major competitive upgrade in crypto payments.

Mswipe’s dual-network BIN sponsorship and compliance stack are hard to replicate quickly; this shortens ALT5’s go-to-market by years. The B2B focus lets ALT5 white-label cards for exchanges, neobanks and fintechs, diversifying revenue beyond trading fees. Real-time forex/crypto swap functionality aligns with rising demand for borderless treasury solutions. Integration risk is moderate because both firms operate API-driven architectures. Key watch-item: maintaining card programme risk thresholds amid volatile crypto cycles. If earn-out targets are met, ALT5’s top line could lift ≥$15 M, material versus its small-cap base.

ALT5 Sigma Corporation (NASDAQ: ALTS) ha depositato un modulo 8-K annunciando l'acquisizione, avvenuta il 9 maggio 2025, di “Mswipe”, un fornitore canadese di soluzioni di pagamento con carta multi-valuta, abilitato sia per valute fiat che criptovalute, disponibile sulle reti Visa e Mastercard.

  • Razionale strategico: La piattaforma B2B di Mswipe amplia l'offerta di ALT5 nell’ambito della liquidazione di asset digitali, integrando carte fisiche e virtuali utilizzabili a livello globale, conversione FX/crypto in tempo reale e un solido sistema di conformità normativa.
  • Controvalore: (i) 1 milione di azioni ALTS vincolate valutate a 6,10 $ ciascuna (~6,1 milioni di $); (ii) 500.000 warrant con durata di quattro anni esercitabili a 5,50 $; (iii) 4,8 milioni di $ in azioni della società spin-off Alyea Therapeutics; (iv) due cambiali della durata di 14 mesi per un totale di circa 1 milione di $ con un interesse del 3,99%; e (v) assunzione/azzeramento di una cambiale esistente da 5,1 milioni di $ a livello target.
  • Pagamento condizionato: I venditori potrebbero ricevere un earn-out una tantum fino a 20 milioni di $ (in contanti o azioni) se le controllate operative raggiungono un fatturato annualizzato o effettivo pari o superiore a 15 milioni di $.
  • Sono stati depositati i bilanci Mswipe auditati per gli esercizi FY25/FY24 (Ex. 99.1) e i rendiconti combinati pro-forma non auditati (Ex. 99.2); inoltre, il 13 maggio 2025 è stato diffuso un comunicato stampa (Ex. 99.3).

Non sono state fornite indicazioni immediate su ricavi o utili per azione. La transazione dovrebbe concludersi senza intoppi mentre ALT5 integra l’emissione delle carte, puntando a collegare gli asset digitali con i tradizionali sistemi di pagamento.

ALT5 Sigma Corporation (NASDAQ: ALTS) presentó un formulario 8-K anunciando la adquisición el 9 de mayo de 2025 de “Mswipe”, un proveedor canadiense de soluciones de tarjetas de pago multi-moneda, compatibles con moneda fiduciaria y criptomonedas, disponibles en las redes Visa y Mastercard.

  • Justificación estratégica: La plataforma B2B de Mswipe amplía la oferta existente de ALT5 en liquidación de activos digitales, añadiendo tarjetas físicas y virtuales de uso global, conversión en tiempo real de FX/crypto y un cumplimiento normativo sólido.
  • Consideración: (i) 1 millón de acciones restringidas de ALTS valoradas en $6.10 cada una (~$6.1 millones); (ii) 500,000 warrants a cuatro años ejercitables a $5.50; (iii) $4.8 millones en acciones de la escisión Alyea Therapeutics; (iv) dos pagarés a 14 meses por un total de aproximadamente $1 millón con interés del 3.99%; y (v) asunción/reinicio de un pagaré existente por $5.1 millones a nivel objetivo.
  • Pago contingente: Los vendedores podrían recibir un pago adicional único de hasta $20 millones (en efectivo o acciones) si las subsidiarias operativas alcanzan ingresos anuales o efectivos iguales o superiores a $15 millones.
  • Se presentaron los estados financieros auditados de Mswipe para FY25/FY24 (Ex. 99.1) y los estados combinados pro forma no auditados (Ex. 99.2); además, se emitió un comunicado de prensa el 13 de mayo de 2025 (Ex. 99.3).

No se proporcionaron previsiones inmediatas de ingresos o ganancias por acción. Se espera que la transacción se cierre sin problemas mientras ALT5 integra la emisión de tarjetas, con el objetivo de conectar los activos digitales con los sistemas tradicionales de pago.

ALT5 Sigma Corporation (NASDAQ: ALTS)는 2025년 5월 9일 캐나다 기반의 다중 통화, 법정화폐 및 암호화폐 지원 결제 카드 솔루션 제공업체인 “Mswipe” 인수를 발표하는 8-K를 제출했습니다. Mswipe의 솔루션은 Visa 및 Mastercard 네트워크에서 이용 가능합니다.

  • 전략적 배경: Mswipe의 B2B 플랫폼은 ALT5의 기존 디지털 자산 결제 서비스를 확장하여 전 세계에서 사용할 수 있는 실물 및 가상 카드, 실시간 FX/암호화폐 환전 및 강력한 컴플라이언스를 추가합니다.
  • 대가: (i) 주당 6.10달러로 평가된 100만 주의 제한된 ALTS 주식 (~610만 달러); (ii) 행사가 5.50달러인 4년 만기 워런트 50만 주; (iii) 스핀오프 회사 Alyea Therapeutics 주식 480만 달러 상당; (iv) 3.99% 이자의 14개월 만기 약속어음 2건, 총 약 100만 달러; (v) 기존 510만 달러 규모의 타깃 레벨 노트 인수 및 재설정.
  • 조건부 지급: 운영 자회사가 연간 또는 실제 매출 1,500만 달러 이상을 달성할 경우 판매자는 최대 2,000만 달러(현금 또는 주식)의 일회성 추가 보상을 받을 수 있습니다.
  • 감사된 FY25/FY24 Mswipe 재무제표(Ex. 99.1) 및 감사되지 않은 프로포르마 결합 재무제표(Ex. 99.2)가 제출되었으며, 2025년 5월 13일 보도자료(Ex. 99.3)가 발표되었습니다.

즉각적인 매출 또는 주당순이익 전망은 제공되지 않았습니다. 거래는 ALT5가 카드 발행을 통합하면서 원활하게 마무리될 것으로 예상되며, 디지털 자산과 전통적인 결제 시스템을 연결하는 것을 목표로 합니다.

ALT5 Sigma Corporation (NASDAQ : ALTS) a déposé un formulaire 8-K annonçant l'acquisition, effective au 9 mai 2025, de « Mswipe », un fournisseur canadien de solutions de cartes de paiement multi-devises, compatibles avec les monnaies fiduciaires et cryptomonnaies, disponibles sur les réseaux Visa et Mastercard.

  • Justification stratégique : La plateforme B2B de Mswipe étend l'offre existante d'ALT5 en matière de règlement d'actifs numériques en ajoutant des cartes physiques et virtuelles utilisables mondialement, une conversion FX/crypto en temps réel et une conformité rigoureuse.
  • Contrepartie : (i) 1 million d'actions ALTS restreintes valorisées à 6,10 $ chacune (~6,1 M$) ; (ii) 500 000 bons de souscription de quatre ans exerçables à 5,50 $ ; (iii) 4,8 M$ en actions de la société dérivée Alyea Therapeutics ; (iv) deux billets à ordre de 14 mois totalisant environ 1 M$ à un taux d'intérêt de 3,99 % ; et (v) prise en charge/remise à zéro d'un billet à ordre existant de 5,1 M$.
  • Paiement conditionnel : Les vendeurs peuvent recevoir un earn-out unique allant jusqu'à 20 M$ (en numéraire ou en actions) si les filiales opérationnelles atteignent un chiffre d'affaires annuel ou réel supérieur ou égal à 15 M$.
  • Les états financiers audités de Mswipe pour les exercices FY25/FY24 (Ex. 99.1) ainsi que les états pro forma combinés non audités (Ex. 99.2) ont été déposés ; un communiqué de presse (Ex. 99.3) a été publié le 13 mai 2025.

Aucune prévision immédiate de chiffre d'affaires ou de bénéfice par action n'a été fournie. La transaction devrait se clôturer sans encombre tandis qu'ALT5 intègre l'émission de cartes, visant à relier les actifs numériques aux systèmes de paiement traditionnels.

ALT5 Sigma Corporation (NASDAQ: ALTS) reichte ein 8-K ein und gab die Übernahme von „Mswipe“ zum 9. Mai 2025 bekannt, einem kanadischen Anbieter von Multiwährungs-Zahlungskartenlösungen, die sowohl Fiat- als auch Krypto-Zahlungen über Visa- und Mastercard-Netzwerke ermöglichen.

  • Strategischer Hintergrund: Die B2B-Plattform von Mswipe erweitert das bestehende Angebot von ALT5 im Bereich der Abwicklung digitaler Vermögenswerte durch global einsetzbare physische und virtuelle Karten, Echtzeit-FX-/Krypto-Umrechnung und umfassende Compliance.
  • Gegenleistung: (i) 1 Million eingeschränkte ALTS-Aktien im Wert von je 6,10 $ (~6,1 Mio. $); (ii) 500.000 vierjährige Warrants mit Ausübungspreis von 5,50 $; (iii) 4,8 Mio. $ in Aktien des Spin-offs Alyea Therapeutics; (iv) zwei 14-monatige Schuldscheine über insgesamt ca. 1 Mio. $ mit 3,99 % Zinsen; und (v) Übernahme/Neufestsetzung eines bestehenden Schuldscheins in Höhe von 5,1 Mio. $.
  • Bedingte Auszahlung: Die Verkäufer können eine einmalige Earn-out-Zahlung von bis zu 20 Mio. $ (in bar oder Aktien) erhalten, falls die operativen Tochtergesellschaften einen annualisierten oder tatsächlichen Umsatz von ≥ 15 Mio. $ erreichen.
  • Die geprüften Finanzberichte von Mswipe für FY25/FY24 (Ex. 99.1) sowie die ungeprüften pro-forma-Konzernabschlüsse (Ex. 99.2) wurden eingereicht; eine Pressemitteilung (Ex. 99.3) wurde am 13. Mai 2025 veröffentlicht.

Es wurden keine unmittelbaren Umsatz- oder Ergebnisprognosen gegeben. Die Transaktion soll nahtlos abgeschlossen werden, während ALT5 die Kartenausgabe integriert und darauf abzielt, digitale Vermögenswerte mit traditionellen Zahlungssystemen zu verbinden.

0001734342false00017343422025-07-232025-07-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 23, 2025
amerantimagea03.jpg 
Amerant Bancorp Inc.
(Exact name of registrant as specified in its charter) 
Florida 001-38534 65-0032379
(State or other jurisdiction
of incorporation
 (Commission
file number)
 (IRS Employer
Identification Number)
220 Alhambra Circle
Coral Gables, Florida
33134
(Address of principal executive offices)(Zip Code)
(305) 460-8728
      (Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolsName of exchange on which registered
Class A Common StockAMTBNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 2.02 Results of Operations and Financial Condition

On July 23, 2025, Amerant Bancorp Inc. (the "Company") issued a press release to report the Company’s financial results for the fiscal quarter ended June 30, 2025. The release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference to this Item 2.02.

In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure

On July 24, 2025, the Company will hold a live audio webcast to discuss its financial results for the fiscal quarter ended June 30, 2025. In connection with the webcast, the Company is furnishing to the U.S. Securities and Exchange Commission the earnings slide presentation attached as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference to this Item 7.01.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.2 attached hereto, is being “furnished” and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01 Other Events.

On July 23, 2025, the Company announced that, on July 23, 2025, its Board of Directors declared a cash dividend of $0.09 per share of common stock. The dividend is payable on August 29, 2025, to shareholders of record at the close of business on August 15, 2025. A copy of the press release is attached hereto as Exhibit 99.3 and is incorporated herein by reference..

Item 9.01 Financial Statements and Exhibits
Number
Exhibit
99.1
Press Release of Amerant Bancorp Inc., dated July 23, 2025
99.2
Earnings slide presentation of Amerant Bancorp Inc., dated July 24, 2025
99.3
Press Release of Amerant Bancorp Inc., dated July 23, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 23, 2025 Amerant Bancorp Inc.
    
  By: /s/ Julio V. Pena
    Name: Julio V. Pena
    Title:  Executive Vice President,
Associate General Counsel and Corporate Secretary

FAQ

What company did ALT5 Sigma acquire in May 2025?

ALT5 acquired Mswipe, a provider of multi-currency fiat and crypto payment card services.

How much did ALT5 pay for Mswipe?

Consideration includes ~$6.1 M in ALTS stock, 0.5 M warrants, $4.8 M Alyea shares, ≈$1 M in new notes and assumption of a $5.1 M note.

Is there an earn-out tied to the Mswipe acquisition?

Yes. Sellers may receive up to $20 M if the operating subsidiaries generate ≥$15 M revenue.

Will the acquisition dilute current ALTS shareholders?

Issuing 1 M shares and 0.5 M warrants could add roughly 6 % dilution based on an estimated 25 M share base.

Where can investors find Mswipe’s historical financials?

Audited FY25/FY24 statements are filed as Exhibit 99.1 to the 8-K.

Did ALT5 provide pro-forma financial impact?

Unaudited pro-forma combined statements are available in Exhibit 99.2.
Amerant Bancorp Inc

NYSE:AMTB

AMTB Rankings

AMTB Latest News

AMTB Latest SEC Filings

AMTB Stock Data

834.49M
34.97M
15.87%
71.86%
3.37%
Banks - Regional
National Commercial Banks
Link
United States
CORAL GABLES